BGI Genomics (300676.SZ) has announced a forecasted pre-tax loss, expecting a net loss of 750 million to 920 million yuan in 2024, turning from profit to loss.

21/01/2025

GMT Eight

BGI Genomics(300676.SZ) released its 2024 performance forecast, with the company expecting a net loss attributable to shareholders of the listed company of 750 million to 920 million yuan in 2024, turning from profit to loss; and a net loss of 730 million to 950 million yuan after deducting non-recurring gains and losses, also turning from profit to loss.

Hiconics Eco-energy Technology (300048.SZ) announced a pre-tax profit, expecting an annual net profit of 10-15 million yuan, turning losses into profits.

Landfar Bio-medicine (000504.SZ) forecasts a net profit of 12.5 million to 15.5 million yuan in 2024, turning a loss into a profit from the same period last year.

Contact: contact@gmteight.com

BGI Genomics (300676.SZ) has announced a forecasted pre-tax loss, expecting a net loss of 750 million to 920 million yuan in 2024, turning from profit to loss.

RECOMMEND

US Stock Market Move | The weight loss drug Cagrisema's clinical trial results did not meet expectations. Novo Nordisk A/S Sponsored ADR Class B (NVO.US) dropped more than 5%.

Asiayang Group (01907) is planning an asset + cash transaction, and may take control of SINOHYTEC (688339.SH,02402) to expand its hydrogen industry chain layout.

Former US Treasury Secretary Mnuchin: Market reaction to Trump administration policies is excessive and unlikely to lead to economic recession.